UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): August 27, 2015
SIENTRA, INC.
(Exact Name of Registrant as Specified in Its Charter)
|
Delaware |
|
001-36709 |
|
20-5551000 |
|
(State or Other Jurisdiction |
|
(Commission |
|
(IRS Employer |
420 South Fairview Avenue, Suite 200
Santa Barbara, CA 93117
(Address of Principal Executive Offices and Zip Code)
(805) 562-3500
(Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events.
On August 27, 2015, Sientra, Inc. (the “Company”) issued a press release announcing that that it is launching a new implant, the Style 107, a smooth round breast implant integrating High-Strength Cohesive HSC+ gel, the Company’s most cohesive silicone gel which until now was only available in anatomically shaped implants. The Company also announced the launch of The Orange Dot campaign on RealSelf.com, the largest online consumer resource for breast augmentation. A copy of the press release is furnished as Exhibit 99.1 and is incorporated herein by reference.
This information contained or incorporated herein, including the press release furnished as Exhibit 99.1, is being furnished, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any of the Company’s filings, whether made before or after the date hereof, regardless of any general incorporation language in any such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
|
Exhibit No. |
|
Description |
|
99.1 |
|
Press release, dated August 27, 2015, entitled “Sientra Launches First-in-Kind 5th Generation Round Breast Implants.” |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereto duly authorized.
|
|
SIENTRA, INC. | |
|
|
| |
|
Dated: August 27, 2015 |
By: |
/s/ Joel Smith |
|
|
|
Joel Smith |
|
|
|
General Counsel, Secretary and Chief Compliance Officer |